For both Zepbound and Retatrutide, there are concerns about: Pancreatitis (inflammation of the pancreas) Gallbladder problems Thyroid tumors (Zepbound includes a warning about medullary thyroid carcinoma based on animal studies) Low blood sugar, especially if combined with other diabetes medications People with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should not take these drugs
Participants in the retatrutide trials "report decreased appetite or increased satiety," Jastreboff said
Does Medicare cover GLP-1s for weight loss
Feel the vial temperature
AOD-9604 is available in Canada as a 5 mg research vial from suppliers like Red Fox Peptides, priced at $55 CAD with shipping from British Columbia
Consider verified vendors with third-party testing, and review resources like the complete retatrutide buying guide and evaluations of specific suppliers such as Peptide Sciences , Paradigm Peptides , and ZLZ Peptide
